Cytoplasmic translocated BCL6 was degraded by the ubiquitin/proteasome pathway, and the degradation of BCL6 induced cyclin D2 expression in gastric cancer cell lines that expressed endogenous BCL6, HB-EGF-CTF, and cyclin D2. The gene discussed is BCL6; the disease is gastric cancer.